# NMDA Enhancement Combined With Omega-3 for Early Dementia

> **NCT05181189** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Omega 3 Fatty Acids
- Dementia

## Interventions

- **DRUG:** DAOIB+Omega-3
- **DRUG:** DAOIB+Placebo

## Key facts

- **NCT ID:** NCT05181189
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05181189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05181189, "NMDA Enhancement Combined With Omega-3 for Early Dementia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05181189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*